Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Acute respiratory failure and mechanical ventilation in pregnant patient: A narrative review of literature.

Bhatia PK, Biyani G, Mohammed S, Sethi P, Bihani P.

J Anaesthesiol Clin Pharmacol. 2016 Oct-Dec;32(4):431-439. doi: 10.4103/0970-9185.194779. Review.

2.

Environmental factors related to the occurrence of oral clefts in a Brazilian subpopulation.

Campos Neves AT, Volpato LE, Espinosa MM, Aranha AM, Borges AH.

Niger Med J. 2016 May-Jun;57(3):167-72. doi: 10.4103/0300-1652.184064.

3.

A Multisite Study of Oral Clefts and Associated Abnormalities in Thailand: The Epidemiologic Data.

Chowchuen B, Thanaviratananich S, Chichareon V, Kamolnate A, Uewichitrapochana C, Godfrey K.

Plast Reconstr Surg Glob Open. 2016 Jan 7;3(12):e583. doi: 10.1097/GOX.0000000000000570. eCollection 2015 Dec.

4.

A Modified Murine Embryonic Stem Cell Test for Evaluating the Teratogenic Effects of Drugs on Early Embryogenesis.

Yu R, Miyamura N, Okamoto-Uchida Y, Arima N, Ishigami-Yuasa M, Kagechika H, Nishina H.

PLoS One. 2015 Dec 18;10(12):e0145286. doi: 10.1371/journal.pone.0145286. eCollection 2015.

5.

Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice.

Dell'Osso B, Albert U, Atti AR, Carmassi C, Carrà G, Cosci F, Del Vecchio V, Di Nicola M, Ferrari S, Goracci A, Iasevoli F, Luciano M, Martinotti G, Nanni MG, Nivoli A, Pinna F, Poloni N, Pompili M, Sampogna G, Tarricone I, Tosato S, Volpe U, Fiorillo A.

Neuropsychiatr Dis Treat. 2015 Jul 30;11:1885-909. doi: 10.2147/NDT.S83130. eCollection 2015. Review.

6.

Optimizing the treatment of mood disorders in the perinatal period.

Meltzer-Brody S, Jones I.

Dialogues Clin Neurosci. 2015 Jun;17(2):207-18. Review.

7.

Perinatal Generalized Anxiety Disorder: Assessment and Treatment.

Misri S, Abizadeh J, Sanders S, Swift E.

J Womens Health (Larchmt). 2015 Sep;24(9):762-70. doi: 10.1089/jwh.2014.5150. Epub 2015 Jun 30.

8.

Alcohol use disorders in pregnancy.

DeVido J, Bogunovic O, Weiss RD.

Harv Rev Psychiatry. 2015 Mar-Apr;23(2):112-21. doi: 10.1097/HRP.0000000000000070. Review.

9.

Antiepileptic drugs in women with epilepsy during pregnancy.

Gedzelman E, Meador KJ.

Ther Adv Drug Saf. 2012 Apr;3(2):71-87. doi: 10.1177/2042098611433192. Review.

10.

The use of central nervous system active drugs during pregnancy.

Källén B, Borg N, Reis M.

Pharmaceuticals (Basel). 2013 Oct 10;6(10):1221-86. doi: 10.3390/ph6101221.

11.

Comparison of pooled risk estimates for adverse effects from different observational study designs: methodological overview.

Golder S, Loke YK, Bland M.

PLoS One. 2013 Aug 20;8(8):e71813. doi: 10.1371/journal.pone.0071813. eCollection 2013. Review.

12.

Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.

Gur TL, Kim DR, Epperson CN.

Psychopharmacology (Berl). 2013 Jun;227(4):567-82. doi: 10.1007/s00213-013-3115-8. Epub 2013 May 17. Review.

13.

Oral cleft prevention program (OCPP).

Wehby GL, Goco N, Moretti-Ferreira D, Felix T, Richieri-Costa A, Padovani C, Queiros F, Guimaraes CV, Pereira R, Litavecz S, Hartwell T, Chakraborty H, Javois L, Murray JC.

BMC Pediatr. 2012 Nov 26;12:184. doi: 10.1186/1471-2431-12-184.

14.

The treatment of alcohol and opioid dependence in pregnant women.

Heberlein A, Leggio L, Stichtenoth D, Hillemacher T.

Curr Opin Psychiatry. 2012 Nov;25(6):559-64. doi: 10.1097/YCO.0b013e328358ad36. Review.

15.

Pharmacologic management of the opioid neonatal abstinence syndrome.

Kraft WK, van den Anker JN.

Pediatr Clin North Am. 2012 Oct;59(5):1147-65. doi: 10.1016/j.pcl.2012.07.006. Epub 2012 Aug 30. Review.

16.

Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event.

Warren FC, Abrams KR, Golder S, Sutton AJ.

BMC Med Res Methodol. 2012 May 3;12:64. doi: 10.1186/1471-2288-12-64.

17.

Generalised anxiety disorder.

Gale CK, Millichamp J.

BMJ Clin Evid. 2011 Oct 27;2011. pii: 1002. Review.

18.

Impact of physician counseling and perception of teratogenic risks: a survey of 96 nonpregnant women with anxiety.

Behringer T, Rollman BL, Herbeck-Belnap B, Houck PR, Mazumdar S, Schwarz EB.

Prim Care Companion CNS Disord. 2011;13(2). pii: PCC.10m01028. doi: 10.4088/PCC.10m01028.

19.

Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.

Golder S, Loke YK, Bland M.

PLoS Med. 2011 May;8(5):e1001026. doi: 10.1371/journal.pmed.1001026. Epub 2011 May 3. Review.

20.

Clinical characteristics of central European and North American samples of pregnant women screened for opioid agonist treatment.

Unger AS, Martin PR, Kaltenbach K, Stine SM, Heil SH, Jones HE, Arria AM, Coyle MG, Selby P, Fischer G.

Eur Addict Res. 2010;16(2):99-107. doi: 10.1159/000284683. Epub 2010 Feb 17.

Supplemental Content

Support Center